Randomized Control Trial of the Co-Parenting for Resilience Program (NCT06840431) | Clinical Trial Compass
By InvitationNot Applicable
Randomized Control Trial of the Co-Parenting for Resilience Program
United States300 participantsStarted 2024-07-01
Plain-language summary
Because parental divorce has been linked to a significant increase in mental health diagnoses among children, it is important to develop effective interventions that reduce the negative impact of divorce on children. This study assesses the efficacy of the Co-Parenting for Resilience (CPR) resilience program by randomly assigning divorcing individuals to three different forms of the intervention to test whether one or both of versions of CPR are better than reading a self-help book, and whether an in-person version of CPR is more effective than an online version. The three conditions or versions are: 1) an in-person version of CPR taught by a trained non-clinician, 2) an asynchronous fully online version of CPR, and 3) a group that simply reads a self-help book and responds to a knowledge check to ensure the material was read.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* One adult member of a dyad filing for a divorce or legal separation (e.g., non-married couples) in Oklahoma County with a biological minor child aged 4-10,
* Being an English or Spanish speaker,
* Having internet access necessary for the online group (necessary for this randomized trial.
* In the event participants have more than one child, they will be asked to report on their oldest child with the person they are divorcing who is age 10 or under. Focus on the oldest child counterbalances the age distribution of children expected per our preliminary data, thereby facilitating a test of age differences in treatment effects.
Exclusion Criteria:
* Parents under the age of 18,
* Parents who do not consent to randomization,
* Parents who are illiterate.
* Only one member of the dyad will be allowed in the study.
* We also exclude parents for whom the target child is not the biological child of both parents. Stepfamilies, adoptive families, grandparents raising grandchildren, and other family types have dynamics not directly comparable to families with two biological parents and is beyond the scope of this study.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Strengths and Difficulties Questionnaire (SDQ)
Timeframe: Baseline, 3-month follow-up, and 12-month follow-up